Lineage Cell Therapeutics Inc

CEO Culley Brian M Buys 15,000 Shares of Lineage Cell Therapeutics, Boosting Investor Confidence in Biotech Pipeline.

Insider buying by Lineage Cell Therapeutics’ CEO signals confidence in its cell‑therapy pipeline, boosting investor optimism and suggesting a stable valuation path.

Lineage Cell Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/03/2026, 21:22

3 minutes to read

Lineage Cell Therapeutics CEO Secures Nearly 3 Million‑Share Zero‑Cost Option, Signaling Long‑Term Confidence in Biotech Growth

Lineage Cell Therapeutics CEO Brian Culley receives a zero‑priced, 3.25 million‑share option grant—signaling insider confidence and a bullish outlook for investors.

Lineage Cell Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/03/2026, 02:06

3 minutes to read